|
CCNT2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.950500E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.639200E-03 |
| Normal-vs-Stage2 |
7.238900E-04 |
| Normal-vs-Stage3 |
3.68920000000106E-05 |
| Normal-vs-Stage4 |
1.484030E-03 |
| Stage1-vs-Stage2 |
1.016040E-01 |
| Stage1-vs-Stage3 |
1.385850E-02 |
| Stage1-vs-Stage4 |
1.151370E-01 |
| Stage2-vs-Stage3 |
8.680600E-01 |
| Stage2-vs-Stage4 |
9.596800E-01 |
| Stage3-vs-Stage4 |
8.235600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.818200E-04 |
| Normal-vs-AfricanAmerican |
8.682000E-02 |
| Normal-vs-Asian |
1.845230E-01 |
| Caucasian-vs-AfricanAmerican |
6.170800E-01 |
| Caucasian-vs-Asian |
1.007610E-01 |
| AfricanAmerican-vs-Asian |
5.458000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.071930E-02 |
| Normal-vs-Female |
1.756270E-04 |
| Male-vs-Female |
3.047800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.805580E-02 |
| Normal-vs-Age(41-60Yrs) |
4.758400E-04 |
| Normal-vs-Age(61-80Yrs) |
9.54640000000451E-05 |
| Normal-vs-Age(81-100Yrs) |
1.462380E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.369800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.052380E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.688810E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.874000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.604200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.471800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.723600E-03 |
| Classical-VS-Follicular |
1.884870E-03 |
| Classical-VS-Other |
7.522600E-01 |
| Classical-VS-Normal |
1.349760E-02 |
| Tall-VS-Follicular |
5.536400E-01 |
| Tall-VS-Other |
8.567700E-02 |
| Tall-VS-Normal |
8.35300000000538E-05 |
| Follicular-VS-Other |
2.116800E-01 |
| Follicular-VS-Normal |
5.55559999999566E-05 |
| Other-VS-Normal |
5.126600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.93000000000244E-05 |
| Normal-vs-N1 |
1.450420E-01 |
| N0-vs-N1 |
6.712000E-02 |
|
|
